Silverfin false false 31/12/2023 01/01/2023 31/12/2023 S Bishop 22/03/2016 A Perkins 12/09/2022 R Perkins 22/03/2016 D Ryan 16/01/2023 01/05/2017 W Summa 20/02/2023 16 September 2024 The principal activity of the Company during the financial year was that of professional membership organisations. 10076719 2023-12-31 10076719 bus:Director1 2023-12-31 10076719 bus:Director2 2023-12-31 10076719 bus:Director3 2023-12-31 10076719 bus:Director4 2023-12-31 10076719 bus:Director5 2023-12-31 10076719 2022-12-31 10076719 core:CurrentFinancialInstruments 2023-12-31 10076719 core:CurrentFinancialInstruments 2022-12-31 10076719 core:ShareCapital 2023-12-31 10076719 core:ShareCapital 2022-12-31 10076719 core:RetainedEarningsAccumulatedLosses 2023-12-31 10076719 core:RetainedEarningsAccumulatedLosses 2022-12-31 10076719 core:ComputerSoftware 2022-12-31 10076719 core:ComputerSoftware 2023-12-31 10076719 2023-01-01 2023-12-31 10076719 bus:FilletedAccounts 2023-01-01 2023-12-31 10076719 bus:SmallEntities 2023-01-01 2023-12-31 10076719 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 10076719 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 10076719 bus:Director1 2023-01-01 2023-12-31 10076719 bus:Director2 2023-01-01 2023-12-31 10076719 bus:Director3 2023-01-01 2023-12-31 10076719 bus:Director4 2023-01-01 2023-12-31 10076719 bus:Director5 2023-01-01 2023-12-31 10076719 core:ComputerSoftware core:TopRangeValue 2023-01-01 2023-12-31 10076719 2022-01-01 2022-12-31 10076719 core:ComputerSoftware 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure

Company No: 10076719 (England and Wales)

ECLINICAL FORUM LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2023
Pages for filing with the registrar

ECLINICAL FORUM LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2023

Contents

ECLINICAL FORUM LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 December 2023
ECLINICAL FORUM LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 December 2023
Note 2023 2022
£ £
Fixed assets
Intangible assets 3 9,675 0
9,675 0
Current assets
Debtors 4 378,752 252,756
Cash at bank and in hand 123,410 262,242
502,162 514,998
Creditors: amounts falling due within one year 5 ( 383,200) ( 385,753)
Net current assets 118,962 129,245
Total assets less current liabilities 128,637 129,245
Net assets 128,637 129,245
Capital and reserves
Called-up share capital 0 0
Profit and loss account 128,637 129,245
Total shareholders' funds 128,637 129,245

For the financial year ending 31 December 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of eClinical Forum Limited (registered number: 10076719) were approved and authorised for issue by the Board of Directors on 16 September 2024. They were signed on its behalf by:

A Perkins
Director
ECLINICAL FORUM LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
ECLINICAL FORUM LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

eClinical Forum Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Bishop Fleming Llp, 10 Temple Back, Bristol, BS1 6FL, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Statement of Financial Position date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal
course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade
discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Computer software 10 years straight line
Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 4 4

3. Intangible assets

Computer software Total
£ £
Cost
At 01 January 2023 0 0
Additions 10,750 10,750
At 31 December 2023 10,750 10,750
Accumulated amortisation
At 01 January 2023 0 0
Charge for the financial year 1,075 1,075
At 31 December 2023 1,075 1,075
Net book value
At 31 December 2023 9,675 9,675
At 31 December 2022 0 0

4. Debtors

2023 2022
£ £
Trade debtors 375,015 237,240
Prepayments and accrued income 0 2,434
VAT recoverable 3,737 13,082
378,752 252,756

5. Creditors: amounts falling due within one year

2023 2022
£ £
Amounts owed to Group undertakings 786 786
Accruals and deferred income 382,047 384,967
Taxation and social security 367 0
383,200 385,753

6. Related party transactions

Transactions with owners holding a participating interest in the entity

2023 2022
£ £
Amounts owed to an associated company 786 786

The loan is interest free and there is no fixed date for repayment.

7. Company Status

The company is a private company limited by guarantee and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation.